drugset / Trial / NCT00588952
Ketamine/Placebo Family History Positive Study
Completed
99 enrolled
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collabVA Connecticut Healthcare System · collab
RandomizedParallel-groupDouble-blindOther
Summary
The proposed study is the first to explore the contribution of brain glutamate systems, a major target of ethanol in the brain, to the vulnerability to develop alcoholism. This study may lead to an enhanced understanding of the underlying neurobiological mechanism in high-risk individuals that may lead to the transition from moderate to excessive use of alcohol.
Timeline
- Start
- 2001-03
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.23 mg/kg | Intravenous |